Mariner Investment Group’s iShares Biotechnology ETF IBB Stock Holding History

Mariner Investment Group’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-370,200	Closed	-$1.51M	–	107
2016 Q2	$1.51M	Sell	370,200 -1,027,500	-74%	-$92.2M	0.51%	53
2016 Q1	$6.48M	Buy	1,397,700 +1,214,700	+664%	+$109M	1.79%	10
2015 Q4	$617K	Sell	183,000 -27,000	-13%	-$2.93M	0.14%	141
2015 Q3	$3.14M	Sell	210,000 -90,000	-30%	-$10.8M	0.63%	51
2015 Q2	$176K	Buy	+300,000	New	+$35.9M	0.05%	171
2015 Q1	–	Sell	-126,000	Closed	-$269K	–	217
2014 Q4	$269K	Sell	126,000 -30,000	-19%	-$2.92M	0.05%	196
2014 Q3	$313K	Buy	156,000 +93,000	+148%	+$8.16M	0.06%	156
2014 Q2	$5K	Buy	+63,000	New	+$4.96M	﹤0.01%	234

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Mariner Investment Group's IBB Position: Q3 2016 in Review

Mariner Investment Group sold out of iShares Biotechnology ETF (IBB) in Q3 2016, closing a stake of 8,400 shares — an estimated $721K sold.

Mariner Investment Group first reported a position in IBB in Q3 2015 and held it in 3 quarters. The position peaked at $3.03M in Q3 2015. 463 funds tracked by Wall St. Rank hold IBB as of Q3 2016.

Mariner Investment Group reported no remaining iShares Biotechnology ETF position as of Q3 2016 after selling out during the quarter.
Mariner Investment Group sold 8,400 iShares Biotechnology ETF shares in Q3 2016, an estimated $721K.
Mariner Investment Group first reported a position in iShares Biotechnology ETF in Q3 2015 and held it in 3 quarters.
Mariner Investment Group's iShares Biotechnology ETF position peaked at $3.03M in Q3 2015.
463 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2016.

Based on Mariner Investment Group's 13F filing for Q3 2016, filed 3 Nov 2016.